Agios Pharma shares jump 16% as US FDA expands approval for blood disorder drug

Shares of Agios Pharmaceuticals jumped nearly 16% on Wednesday ⁠after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.